The information in these press releases is accurate only as of the date of the particular press release. Theravance does not update press releases once they have been made public. Press releases may contain forward-looking statements and future events or actual results could differ materially from those projected in the forward-looking statements.

All Releases
View Summary GSK and Theravance Announce Phase III Study of Fluticasone Furoate/Vilanterol in COPD Commenced to Support Potential Future Filing in Japan
Apr 22, 2014
PDF 112.2 KB Add to Briefcase
View Summary Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
Apr 21, 2014
PDF 17.2 KB Add to Briefcase
View Summary Theravance to Report First Quarter 2014 Financial Results on May 6, 2014
Apr 15, 2014
PDF 10.5 KB Add to Briefcase
View Summary Theravance Announces Initiation of Phase 2b Study With TD-4208, an Investigational LAMA for the Treatment of COPD
Apr 10, 2014
PDF 13.3 KB Add to Briefcase
View Summary Theravance Appoints Kevin Kwok, Head of Talent Acquisition and Strategy
Apr 1, 2014
PDF 13.8 KB Add to Briefcase
View Summary Theravance to Present at the 13th Annual Needham Healthcare Conference
Mar 26, 2014
PDF 13.3 KB Add to Briefcase
View Summary GSK and Theravance Announce Positive Results From Studies Comparing ANORO(TM) ELLIPTA(TM) With SERETIDE(R) DISKUS(R) and ADVAIR(R) DISKUS(R) in Patients With COPD
Mar 14, 2014
PDF 76.8 KB Add to Briefcase
View Summary Patient Recruitment Completes in Landmark RELVAR(R)/BREO(R) ELLIPTA(R) Study to Understand Mortality and MorbidITy (SUMMIT) in COPD
Mar 13, 2014
PDF 162.0 KB Add to Briefcase
View Summary Theravance Announces Update to Planned Separation of Late-Stage Partnered Respiratory Assets from Biopharmaceutical Operations
Mar 3, 2014
PDF 16.7 KB Add to Briefcase
View Summary Theravance to Present at Investor Conferences in March 2014
Feb 25, 2014
PDF 13.5 KB Add to Briefcase
View Summary Anoro(R) (umeclidinium / vilanterol) Receives Positive Opinion From the CHMP in Europe for the Treatment of COPD
Feb 20, 2014
PDF 20.3 KB Add to Briefcase
View Summary Theravance Reports 2013 Financial Results
Feb 6, 2014
PDF 127.5 KB Add to Briefcase
View Summary Theravance to Present at the Leerink Global Healthcare Conference
Jan 30, 2014
PDF 13.3 KB Add to Briefcase
View Summary Theravance Appoints Frank Pasqualone Senior Vice President, Operations
Jan 23, 2014
PDF 12.8 KB Add to Briefcase
View Summary Theravance to Report Fourth Quarter and Full Year 2013 Financial Results on February 6, 2014
Jan 22, 2014
PDF 10.6 KB Add to Briefcase
View Summary Theravance to Present at the 32nd Annual J.P. Morgan Healthcare Conference
Jan 9, 2014
PDF 13.3 KB Add to Briefcase
View Summary ANORO(TM) ELLIPTA(TM) Approved as First Once-Daily Dual Bronchodilator for the Treatment of COPD in the US
Dec 18, 2013
PDF 162.8 KB Add to Briefcase
View Summary GSK and Theravance Announce Positive Results From Pivotal Phase III Study for Fluticasone Furoate/Vilanterol in Asthma
Dec 6, 2013
PDF 161.7 KB Add to Briefcase
View Summary Theravance to Present at the 25th Annual Piper Jaffray Healthcare Conference
Nov 21, 2013
PDF 13.4 KB Add to Briefcase
View Summary RELVAR(R) ELLIPTA(R) Receives European Marketing Authorisation for the Treatment of Asthma and COPD
Nov 18, 2013
PDF 24.8 KB Add to Briefcase
Showing 1-20 of 190 Page: 1 2 3 4 5 ... 10  Next 20
Add to Briefcase = add release to Briefcase
Search
Investor Relations
Proxy Materials
Form content here please :)